 |
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
|
Board of Directors
Dr. Ralf Brandt (PhD),
Chief Executive Officer & Managing Director
Dr. Brandt is the co-founder of vivoPharm. He is a biochemist and cell biologist with over 15 years experience in research programs of experimental oncology. Furthermore, he has immense experience in in vivo pharmacology and anti-cancer drug profiling. He received his Licence (BSc in Biochemistry and Animal Physiology) in 1986, and his PhD (in Biochemistry) in 1991 from the Martin-Luther University of Halle-Wittenberg, Germany. Dr. Brandt was employed at research positions at the National Cancer Institute in Bethesda, MD, USA and at Schering AG, Germany. Since 1990, Dr. Brandt has been active in the field of preclinical oncology. He led the Tumour Biology program at Novartis Pharma AG, Switzerland and established several transgenic mouse lines developing tumours under the control of oncogenes.
During Dr. Brandt's long career in the pharmaceutical industry he has acquired significant knowledge and expertise in leading business units and representation of services to the pre-clinical research market.
Dr Brandt is a member of the Scientific Advisory Board at Receptor Inc. in Toronto Canada
Brenton Wright
Non-Executive Director
Mr. Wright is an experienced executive with senior roles in relationship management, team leadership, business development and strategic planning in the commercial development, government and non-government sectors. He has a unique combination of precise analytical skills and creative "outside the square" problem solving skills. He is a clear, persuasive communicator and skilled negotiator and a trusted manager and leader with an open, consultative style. His recent clients include numerous departments of the South Australian government, ETSA utilities, Prescott Securities, Tenix Defence, Electronic Data Systems and many others.
Kym Weir
Non-Executive Director
Mr. Weir originally had experience in all facets of a chartered accountant's practice. In recent years, however, he has specialised in corporate recovery and corporate advisory work, in which he has handled numerous administrations, business reviews, business valuations, mergers and acquisitions and strategic planning assignments. Mr. Weir has served on the boards of organisations including the National Basketball League, Challenger Beston Ltd., the Motor Accident Commission, the Australian Institute of Fitness and many others. He currently holds the position of Managing Director of Rundle Capital Partners Ltd., which is an Adelaide based merchant bank firm concentrating on corporate advisory, capital raising, and investor relation work.